Stem Cell Medical Reports for: Covid 19
Author or authors of report : Zhi-Xue Zheng
Date of report : 2021-12-16
Covid 19
This report is an invited article and was externally peer-reviewed, with no specific commissioning body mentioned.
Summary of the Main Points/Findings: Background and Objective: The article reviews the potential of mesenchymal stem cell (MSC) therapy as a treatment for COVID-19. COVID-19, caused by SARS-CoV-2, has become
Author or authors of report : Cai Yan, Minjie Hu, Rongjuan Dai
Date of report : 2023-08-09
Covid 19
The Fund project of University of South China for Prevention and Control of COVID‐19 The Scientific Research Fund Project of Hunan Provincial Health Commission The Special Fundamental Research Project of COVID‐19 Prevention and Control of Hengyang Science
Summary of the Main Points/Findings: Background and Objective: The study titled "Safety and efficacy of mesenchymal stem cells in COVID‐19 patients: A systematic review and meta-analysis" aimed to evaluate the
Author or authors of report : Tian-Tian Li, Bo Zhang, Hui Fang, Ming Shi, Wei-Qi Yao, Yuanyuan Li, Chao Zhang, Jinwen Song, Lei Huang, Zhe Xu, Xin Yuan, Jun-Liang Fu, Cheng Zhen, Yu Zhang, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, Tengyun Dong, Ruidan Bai, Lulu Zhao, Jianming Cai, Jin
Date of report : 2023-05-10
Covid 19
The National Key Research and Development Program of China, The Innovation Platform for Academicians of Hainan Province, and the Fund of National Clinical Center for Infectious Diseases, PLA General Hospital.
Summary of the Main Points/Findings: Background and Objective: The study aimed to evaluate the long-term safety and efficacy of human mesenchymal stem cell (MSC) treatment in severe COVID-19 patients over